查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571437

基因毒性測試市場規模、佔有率、趨勢分析報告：按類型、按產品、按測定、按應用、按地區、細分市場預測，2024-2030 年

Genetic Toxicology Testing Market Size, Share & Trends Analysis Report By Type (In Vitro, In Vivo), By Product (Reagents & Consumables, Assays Kit, Services), By Assay, By Application, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

遺傳毒性測試市場的成長和趨勢：

Grand View Research, Inc.的最新報告顯示，預計到2030年，全球基因毒性檢測市場規模將達到35.7億美元，2024年至2030年的複合年成長率為11.6%。

個人化藥物的日益普及，加上全球細胞和基因療法的進步，正在推動對基因毒性的需求。例如，美國FDA 為細胞和基因治療製造商制定了指導文件。根據該指南，臨床前研究中毒性和生理參數鑑定的資訊將指南臨床實驗藥物的臨床監測。

擴大採用藥物基因組學來支持個人化醫療並降低藥物不良毒性風險，預計將對產業的成長產生重大影響。此外，荷蘭藥物遺傳學工作組 (DPWG)、臨床藥物遺傳學實施聯盟 (CPIC)、法國國家藥物遺傳學網路和加拿大藥物基因組藥物安全網路 (CPNDS) 等組織支持藥物基因組學測試的解釋和我們發布了針對基因組合的建議的臨床指南。

同樣，市場參與者正在採取各種策略來擴大其在多個細分市場的足跡。例如，2021年11月，Labcorp宣布收購提供非臨床測試服務的CRO Toxikon。此次收購預計將加強 Labcorp 的毒理學業務，而 Toxikon 的位置將使 Labcorp 能夠與該地區的知名生物技術和製藥公司開展非臨床業務。

預計 COVID-19 大流行將對基因毒性測試市場的成長產生中性影響。許多研究人員正在利用基因毒性來評估藥物對抗 COVID-19 病毒的有效性。例如，2020年9月，一個研究小組評估了Chloroquine（CQ）和羥氯喹（HCQ）作為病毒預防藥物的效果。評估了各種藥物和化學物質的遺傳毒性。此類使用基因毒性測試作為評估工具的研究預計將支持 COVID-19 高峰期間的穩定成長。

對新型食品及其進口產品的需求不斷成長預計將促進市場成長。 Charles River Laboratories 是新型食品毒理學評估的主要企業之一。該公司提供新穎的食品檢測，包括遺傳毒性，包括體內微核試驗、艾姆斯試驗、體外哺乳動物細胞微核試驗和體內彗星試驗。同樣，2021 年 1 月，歐洲食品安全局 (EFSA) 發布了對昆蟲食品的評估。這是該機構首次對昆蟲產品作為新型食品進行此類評估。歐洲食品安全局每年都會收到大量申請，其中包括基於藻類食品、植物和非本地水果的草藥產品。

另一方面，遺傳毒理學的資訊搜尋能力有限。根據病理學測試解釋組織的說法，基因測試提供有關特定疾病或正在測試的基因的資訊。儘管未經測試，但它不涵蓋有關可能存在的其他遺傳疾病的資訊。同樣，我們無法辨識所有導致疾病的基因突變，也無法顯示疾病的嚴重程度。因此，這些限制預計將阻礙基因毒性測試行業的成長。

基因毒性測試市場報告亮點

  • 按類型分類，試管內細分市場在 2023 年佔據最大收益佔有率，達到 65.1%，預計在估計和預測期內將保持類似的勢頭。這是由於成本效益、快速結果、減少動物使用、倫理考慮、監管接受、技術進步以及對各種產品的遺傳毒性測試的認知提高等好處。
  • 按應用分類，製藥和生物技術領域佔最大的銷售佔有率，2023年將達到44.9%。
  • 按產品分類，服務業在 2023 年佔據最大收益佔有率，達到 52.1%。這是由於多種因素造成的，包括對外包服務的需求增加、測試程序的複雜性增加以及對專業知識的需求。
  • 從分析來看，彗星分析領域將在 2023 年佔據市場主導地位。彗星測定，也稱為單細胞凝膠電泳測定，廣泛用於評估 DNA 損傷。彗星檢測可以檢測多種 DNA 損傷，包括單鏈、雙鏈和不完全修復位點。
  • 北美基因毒性測試市場在2023年以40.1%的收益佔有率主導全球市場。該地區的優勢是由於強大的管道投資而增加了藥物開發。
  • 預計亞太地區在預測期內將以最快的複合年成長率擴張。這是因為日本和印度等國家正在收緊有關新食品和藥物開發測試的法規。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章 基因毒性測試市場變數、趨勢和範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 遺傳毒性測試市場分析工具
    • 波特的分析
    • PESTEL分析

第4章基因毒性測試市場：產品估算與趨勢分析

  • 細分儀表板
  • 基因毒性測試市場：產品變異分析，百萬美元，2023 年和 2030 年
  • 試劑/耗材
  • 檢測試劑套件
  • 服務

第5章基因毒性測試市場：類型估計和趨勢分析

  • 細分儀表板
  • 基因毒性測試市場：類型變異分析，百萬美元，2023-2030
  • In vitro
  • In vivo

第6章 基因毒性測試市場：含量估算與趨勢分析

  • 細分儀表板
  • 基因毒性測試市場：檢測變異分析，百萬美元，2023 年和 2030 年
  • 彗星試驗
  • 微核試驗
  • 染色體異常檢測
  • 基因突變檢測
  • 其他

第7章 基因毒性測試市場：應用估算與趨勢分析

  • 細分儀表板
  • 基因毒性測試市場：應用變異分析，百萬美元，2023 年和 2030 年
  • 製藥/生物技術
  • 食品工業
  • 化妝品產業
  • 其他

第8章基因毒性測試市場：區域估計和趨勢分析

  • 2023 年和 2030 年按地區分類的基因毒性測試市場佔有率，百萬美元
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭格局

  • 最新趨勢與影響分析：主要市場參與企業
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Thermo Fisher Scientific, Inc.
    • Charles River Laboratories
    • Laboratory Corporation of America Holdings
    • Eurofins Scientific
    • Jubilant Ingrevia Limited.
    • Syngene International Limited
    • Gentronix, Inotiv
    • Creative Bioarray
    • MB Research Laboratories
簡介目錄
Product Code: GVR-4-68039-981-3

Genetic Toxicology Testing Market Growth & Trends:

The global genetic toxicology testing market size is anticipated to reach USD 3.57 billion by 2030, registering to grow at a CAGR of 11.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising usage of personalized medicines, combined with the development of cell and gene therapy across the globe is enhancing the demand for genotoxicity. For instance, the U.S. FDA has designed guidance documents for the manufacturers of cell and gene therapy. According to the guidance, information on the identification of toxicities and physiologic parameters in preclinical studies can assist in guiding clinical monitoring for the investigational product.

Increasing implementation of pharmacogenomics to support personalized medicine usage and reduced risk of adverse drug toxicity is considered to have a significant impact on the growth of the industry. Moreover, organizations, such as the Dutch Pharmacogenetics Working Group (DPWG), Clinical Pharmacogenetics Implementation Consortium (CPIC), the French National Network of Pharmacogenetics, and the Canadian Pharmacogenomics Network for Drug Safety (CPNDS), have issued clinical guidelines with a primary focus on the pharmacogenomics testing interpretation and recommendation on therapeutic specific drug-gene pairs.

Similarly, the market players are indulging in various strategies to expand their footprint in multiple segments. For instance, in November 2021, Labcorp announced the acquisition of Toxikon, a Contract Research Organization (CRO) with offerings in nonclinical testing services. Through this acquisition, Labcorp is anticipated to strengthen its toxicology business and Toxikon's location enables Labcorp to engage with known biotech and pharmaceutical companies in the region for non-clinical work.

The COVID-19 pandemic is anticipated to have a neutral impact on the genetic toxicology testing market growth. Numerous researchers employed genotoxic to assess the effects of drugs against the COVID-19 virus. For instance, in September 2020, a team of researchers evaluated the impact of Chloroquine (CQ) and Hydroxychloroquine (HCQ) as prophylactic drugs against the virus. The genetic toxicology of various drugs and chemicals was assessed. Such studies using genetic toxicology testing as a tool of assessment are anticipated to support stable growth during the peak of COVID-19.

The rising demand for novel food and its imports is expected to be a contributor to market growth. Charles River Laboratories is one of the major players offering toxicology assessments on novel foods. They offer novel food analysis including genotoxicity, which consist of in vivo micronucleus test, Ames study, In Vitro Mammalian Cell Micronucleus, and in the vivo comet assay. Similarly, in January 2021, EFSA published its evaluation of insect-derived food. It is the first kind of assessment conducted by the institution on the insect product as a novel food. Every year, EFSA receives a large number of applications, consisting of herbal products based on algae foods, plants, and non-indigenous fruits.

On the other hand, the ability to retrieve information through genetic toxicology is limited. According to the Pathology Tests Explained organization, genetic tests offer information regarding the specific diseases/gene that is being tested. It does not cover information about other genetic diseases that might be present but have not been tested. Similarly, it cannot identify all the variations of genes that cause the diseases, and also it does not showcase the severity of the diseases. Hence, these limitations are anticipated to hamper the growth of the genetic toxicology industry.

Genetic Toxicology Testing Market Report Highlights:

  • By type, the in vitro segment held the largest revenue share of 65.1% in 2023 and is estimated to have similar momentum during the forecast period. This is attributed to advantages which include cost-effectiveness, faster results, reduced animal usage, ethical considerations, regulatory acceptance advancements in technology, and increasing awareness of genetic toxicology testing in various products.
  • By application,the pharmaceutical and biotechnology segment held the largest revenue share of 44.9% in 2023.
  • By product, the service segment captured the largest revenue share of 52.1% in 2023. This is attributed to several factors such as the increasing demand for outsourced services, the complexity of testing procedures, and the need for specialized expertise.
  • By Assay,the comet assay segment dominated the market in 2023. The comet assay, also known as single-cell gel electrophoresis assay, is widely used for assessing DNA damage, it can detect a broad range of DNA damage, including single-strand breaks, double-strand breaks and incomplete repair sites.
  • The North America genetic toxicology testing market dominated the global market with a revenue share of 40.1% in 2023. The regional dominance can be attributed to increasing drug development with strong investments in pipelines.
  • Asia Pacific is projected to expand at the fastest CAGR over the forecast period, due to developments by countries such as Japan and India in tightening the regulations on testing of novel food and drug development.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Genetic Toxicology Testing Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Genetic Toxicology Testing Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Genetic Toxicology Testing Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Genetic Toxicology Testing Market: Product Movement Analysis, USD Million, 2023 & 2030
  • 4.3. Reagents & Consumables
    • 4.3.1. Reagents & Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Assays Kit
    • 4.4.1. Assays Kit Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Genetic Toxicology Testing Market: Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Genetic Toxicology Testing Market: Type Movement Analysis, USD Million, 2023 & 2030
  • 5.3. In vitro
    • 5.3.1. In vitro Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. In vivo
    • 5.4.1. In vivo Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Genetic Toxicology Testing Market: Assay Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Genetic Toxicology Testing Market: Assay Movement Analysis, USD Million, 2023 & 2030
  • 6.3. Comet Assay
    • 6.3.1. Comet Assay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Micronucleus Assay
    • 6.4.1. Micronucleus Assay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Chromosomal Aberration Test
    • 6.5.1. Chromosomal Aberration Test Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Genetic Mutation Test
    • 6.6.1. Genetic Mutation Test Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Genetic Toxicology Testing Market: Application Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Genetic Toxicology Testing Market: Application Movement Analysis, USD Million, 2023 & 2030
  • 7.3. Pharmaceutical & biotechnology
    • 7.3.1. Pharmaceutical & biotechnology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Food Industry
    • 7.4.1. Food Industry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Cosmetics Industry
    • 7.5.1. Cosmetics Industry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Other
    • 7.6.1. Other Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Genetic Toxicology Testing Market: Regional Estimates & Trend Analysis

  • 8.1. Genetic Toxicology Testing Market Share, By Region, 2023 & 2030, USD Million
  • 8.2. North America
    • 8.2.1. North America Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Canada Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. UK.
      • 8.3.2.1. UK Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Germany Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. France Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Italy Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Spain Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Norway Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. China Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. India Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. Australia
      • 8.4.5.1. Australia Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. South Korea
      • 8.4.6.1. South Korea Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Thailand
      • 8.4.7.1. Thailand Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Saudi Arabia Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. UAE Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Genetic Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Heat Map Analysis
  • 9.4. Company Profiles
    • 9.4.1. Thermo Fisher Scientific, Inc.
      • 9.4.1.1. Participant's Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Recent Developments/ Strategic Initiatives
    • 9.4.2. Charles River Laboratories
      • 9.4.2.1. Participant's Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Recent Developments/ Strategic Initiatives
    • 9.4.3. Laboratory Corporation of America Holdings
      • 9.4.3.1. Participant's Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Recent Developments/ Strategic Initiatives
    • 9.4.4. Eurofins Scientific
      • 9.4.4.1. Participant's Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Recent Developments/ Strategic Initiatives
    • 9.4.5. Jubilant Ingrevia Limited.
      • 9.4.5.1. Participant's Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Recent Developments/ Strategic Initiatives
    • 9.4.6. Syngene International Limited
      • 9.4.6.1. Participant's Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Recent Developments/ Strategic Initiatives
    • 9.4.7. Gentronix, Inotiv
      • 9.4.7.1. Participant's Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Recent Developments/ Strategic Initiatives
    • 9.4.8. Creative Bioarray
      • 9.4.8.1. Participant's Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Recent Developments/ Strategic Initiatives
    • 9.4.9. MB Research Laboratories
      • 9.4.9.1. Participant's Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Recent Developments/ Strategic Initiatives